The Role of Vimentin as a Methylation Biomarker for Early Diagnosis of Cervical Cancer

Molecules and Cells - Germany
doi 10.1007/s10059-011-0229-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Human Papillomavirus DNA Methylation as a Potential Biomarker for Cervical Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2012English

Alu Methylation Serves as a Biomarker for Non-Invasive Diagnosis of Glioma

Oncotarget
Oncology
2016English

DNA Methylation Profile at the DNMT3L Promoter: A Potential Biomarker for Cervical Cancer

Epigenetics
Cancer ResearchMedicineMolecular Biology
2007English

PO-296 Elucidating the Potential Role of Cd109 as a Biomarker for Cancer Stem-Like Cells in Cervical Cancer

2018English

The Role of PTEN as a Cancer Biomarker

Oncoscience
Cancer ResearchOncology
2016English

A Novel Biomarker for Cervical Cancer

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2009English

Promoter DNA Methylation Analysis Reveals a Combined Diagnosis of CpG-based Biomarker for Prostate Cancer

Oncotarget
Oncology
2017English

The Role of the Cervicovaginal Microbiome on the Genesis and as a Biomarker of Premalignant Cervical Intraepithelial Neoplasia and Invasive Cervical Cancer

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2019English

Serum microRNA-205 as a Novel Biomarker for Cervical Cancer Patients

Cancer Cell International
Cancer ResearchOncologyGenetics
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy